Haizhi Zhang

Title: Haizhi Zhang: Innovator in Pharmaceutical Research

Introduction

Haizhi Zhang is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of urate transporter inhibitors. With a total of three patents to his name, Zhang's work is characterized by innovation and practical applications in medicine.

Latest Patents

Zhang's latest patents include a crystal form of urate transporter 1 inhibitor and a preparation method and use thereof. This invention provides a crystal form that is notable for its stable state of appearance, enhancing the purity and storage stability of the compound, making it suitable as a pharmaceutical raw material. Another significant patent is a method for preparing a URAT1 inhibitor, specifically 2-((5-bromo-4-((4-bromonaphthalen-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio) acetic acid. This method is advantageous due to its low cost, ease of handling, and applicability to industrialization.

Career Highlights

Haizhi Zhang is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd. His work at this institution has allowed him to focus on innovative solutions in drug development, particularly in the area of urate transporter inhibitors. His contributions have been instrumental in advancing pharmaceutical research.

Collaborations

Zhang has collaborated with notable colleagues, including Guilong Zhao and Changying Liu. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Haizhi Zhang is a key figure in pharmaceutical innovation, with a focus on urate transporter inhibitors. His patents reflect a commitment to improving drug efficacy and stability, contributing to advancements in medical science. His work continues to influence the field and showcases the importance of innovation in pharmaceuticals.